Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
B. C. Selvanesan, K. Meena, A. Beck, L. Meheus, O. Lara, I. Rooman, C. Gravekamp
This study shows that combining nicotinamide with gemcitabine reduces pancreatic tumor growth and improves survival in mice by modulating the immune microenvironment.
bioRxiv · Jun 2, 2020Immunology